Chronic kidney disease

被引:1545
作者
Levey, Andrew S. [1 ]
Coresh, Josef [2 ]
机构
[1] Tufts Med Ctr, William B Schwartz Div Nephrol, Boston, MA 02111 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
GLOMERULAR-FILTRATION-RATE; CLINICAL-PRACTICE GUIDELINES; BLOOD-PRESSURE CONTROL; SERUM CYSTATIN-C; QUALITY-OF-LIFE; POSITION STATEMENT; CARDIOVASCULAR EVENTS; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; MEDICAL PROGRESS;
D O I
10.1016/S0140-6736(11)60178-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney structure and function. The 2002 guidelines for definition and classification of this disease represented an important shift towards its recognition as a worldwide public health problem that should be managed in its early stages by general internists. Disease and management are classified according to stages of disease severity, which are assessed from glomerular filtration rate (GFR) and albuminuria, and clinical diagnosis (cause and pathology). Chronic kidney disease can be detected with routine laboratory tests, and some treatments can prevent development and slow disease progression, reduce complications of decreased GFR and risk of cardiovascular disease, and improve survival and quality of life. In this Seminar we discuss disease burden, recommendations for assessment and management, and future challenges. We emphasise clinical practice guidelines, clinical trials, and areas of uncertainty.
引用
收藏
页码:165 / 180
页数:16
相关论文
共 142 条
[91]   Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease [J].
Palmer, Suetonia C. ;
Navaneethan, Sankar D. ;
Craig, Jonathan C. ;
Johnson, David W. ;
Tonelli, Marcello ;
GargMd, Amit X. ;
Pellegrini, Fabio ;
Ravani, Pietro ;
Jardine, Meg ;
Perkovic, Vlado ;
Graziano, Giusi ;
McGee, Richard ;
Nicolucci, Antonio ;
Tognoni, Gianni ;
Strippoli, Giovanni F. M. .
ANNALS OF INTERNAL MEDICINE, 2010, 153 (01) :23-W23
[92]   Quality of Life in CKD Patients Treated With Erythropoiesis-Stimulating Agents [J].
Parfrey, Patrick S. ;
Wish, Tyler .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (03) :423-425
[93]   Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease [J].
Parfrey, PS ;
Foley, RN ;
Wittreich, BH ;
Sullivan, DJ ;
Zagari, MJ ;
Frei, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2180-2189
[94]   Aliskiren combined with losartan in type 2 diabetes and nephropathy [J].
Parving, Hans-Henrik ;
Persson, Frederik ;
Lewis, Julia B. ;
Lewis, Edmund J. ;
Hollenberg, Norman K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (23) :2433-2446
[95]   A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease [J].
Pfeffer, Marc A. ;
Burdmann, Emmanuel A. ;
Chen, Chao-Yin ;
Cooper, Mark E. ;
de Zeeuw, Dick ;
Eckardt, Kai-Uwe ;
Feyzi, Jan M. ;
Ivanovich, Peter ;
Kewalramani, Reshma ;
Levey, Andrew S. ;
Lewis, Eldrin F. ;
McGill, Janet B. ;
McMurray, John J. V. ;
Parfrey, Patrick ;
Parving, Hans-Henrik ;
Remuzzi, Giuseppe ;
Singh, Ajay K. ;
Solomon, Scott D. ;
Toto, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2019-2032
[96]   Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis [J].
Phrommintikul, Arintaya ;
Haas, Steven Joseph ;
Elsik, Maros ;
Krum, Henry .
LANCET, 2007, 369 (9559) :381-388
[97]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[98]   To have and have not: Health and health care disparities in chronic kidney disease [J].
Powe, NR ;
Madias, NE ;
Harrington, JT ;
Levey, AS ;
Khan, S ;
Kausz, A ;
Jaber, BL ;
Meyer, KB .
KIDNEY INTERNATIONAL, 2003, 64 (02) :763-772
[99]   Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes [J].
Remuzzi, G ;
Benigni, A ;
Remuzzi, A .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (02) :288-296
[100]   Chronic Kidney Disease in the United States: A Public Policy Imperative [J].
Rettig, Richard A. ;
Norris, Keith ;
Nissenson, Allen R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06) :1902-1910